| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Hongli Li, Min Gao, Ziyu Chen, Zhenyu Zhou, Wei Li, Xiaoyang Zhang, Xi Jiang, Lingling Luo, Fei Li, Gaorui Wang, Yu Zhang, Xingxu Huang, Jingning Zhu, Shengjie Fan, Xiaojun Wu, Cheng Huan. Hordenine improves Parkinsonian-like motor deficits in mice and nematodes by activating dopamine D2 receptor-mediated signaling. Phytotherapy research : PTR. 2023-03-08. PMID:36883794. |
parkinson's disease (pd) is a chronic neurodegenerative disease characterized by selective loss of dopaminergic neurons in the substantia nigra pars compacta (snpc) and the striatum, leading to dopamine (da) deficiency in the striatum and typical motor symptoms. |
2023-03-08 |
2023-08-14 |
mouse |
| Narmadhaa Sivagurunathan, Priyadharshini Gnanasekaran, Latchoumycandane Calivaratha. Mitochondrial Toxicant-Induced Neuronal Apoptosis in Parkinson's Disease: What We Know so Far. Degenerative neurological and neuromuscular disease. vol 13. 2023-02-02. PMID:36726995. |
parkinson's disease (pd) is one of the most common progressive neurodegenerative diseases caused by the loss of dopamine-producing neuronal cells in the region of substantia nigra pars compacta of the brain. |
2023-02-02 |
2023-08-14 |
Not clear |
| Jessica K Smith, George D Mellick, Alex M Syke. The role of the endolysosomal pathway in α-synuclein pathogenesis in Parkinson's disease. Frontiers in cellular neuroscience. vol 16. 2023-01-27. PMID:36704248. |
parkinson's disease (pd) is a chronic neurodegenerative disease that is characterized by a loss of dopaminergic neurons in the substantia nigra pars compacta of the midbrain (snpc). |
2023-01-27 |
2023-08-14 |
Not clear |
| Minyoung Oh, Juhyeon Nam, Areum Baek, Ji-Hye Seo, Jung-Il Chae, Seo-Young Lee, Sun-Ku Chung, Byoung Chul Park, Sung Goo Park, Janghwan Kim, Young-Joo Jeo. Neuroprotective Effects of Licochalcone D in Oxidative-Stress-Induced Primitive Neural Stem Cells from Parkinson's Disease Patient-Derived iPSCs. Biomedicines. vol 11. issue 1. 2023-01-21. PMID:36672736. |
parkinson's disease (pd) is one of the most common neurodegenerative diseases caused by the loss of dopaminergic neurons in the substantia nigra pars compacta. |
2023-01-21 |
2023-08-14 |
Not clear |
| Bruk Getachew, Antonei B Csoka, Robert L Copeland, Kebreten F Manaye, Yousef Tizab. Dihydromyricetin Protects Against Salsolinol-Induced Toxicity in Dopaminergic Cell Line: Implication for Parkinson's Disease. Neurotoxicity research. 2022-12-30. PMID:36585544. |
parkinson's disease (pd) is a progressive neurodegenerative disease associated with loss of dopaminergic neurons in the substantia nigra pars compacta. |
2022-12-30 |
2023-08-14 |
human |
| Giselle Prunell, Silvia Olivera-Brav. A Focus on Astrocyte Contribution to Parkinson's Disease Etiology. Biomolecules. vol 12. issue 12. 2022-12-23. PMID:36551173. |
parkinson's disease (pd) is an incurable neurodegenerative disease of high prevalence, characterized by the prominent death of dopaminergic neurons in the substantia nigra pars compacta, which produces dopamine deficiency, leading to classic motor symptoms. |
2022-12-23 |
2023-08-14 |
Not clear |
| Xin-Yi Chen, Cui Liu, Yan Xue, Lei Che. Changed firing activity of nigra dopaminergic neurons in Parkinson's disease. Neurochemistry international. 2022-12-23. PMID:36563966. |
parkinson's disease is the second most common neurodegenerative disease which is characterized by selective degeneration of dopaminergic neurons in the substantia nigra pars compacta. |
2022-12-23 |
2023-08-14 |
Not clear |
| Erlânia Alves de Siqueira, Emanuel Paula Magalhães, Ramon Róseo Paula Pessoa Bezerra de Menezes, Tiago Lima Sampaio, Danya Bandeira Lima, Conceição da Silva Martins, Kelly Rose Tavares Neves, Gerly Anne de Castro Brito, Alice Maria Costa Martins, Glauce Socorro de Barros Vian. Vitamin D3 actions on astrocyte cells: a target for therapeutic strategy in Parkinson's disease? Neuroscience letters. 2022-12-05. PMID:36470505. |
parkinson's disease (pd) is a neurodegenerative disease characterized by the loss of dopaminergic cells in the substantia nigra pars compacta. |
2022-12-05 |
2023-08-14 |
Not clear |
| Xóchitl Flores-Ponce, Adolfo López-Ornelas, Itzel Escobedo-Avila, Mayela Rodríguez-Violante, David Dávila-Ortiz de Montellano, Amín Cervantes-Arriaga, Nancy Monroy-Jaramillo, Iván Velasc. Generation of a human induced pluripotent stem cell line (UNAMi001-A) from a Mexican patient with sporadic Parkinson's disease. Stem cell research. vol 65. 2022-11-25. PMID:36427474. |
parkinson's disease (pd) is a neurodegenerative disease caused by progressive loss of dopaminergic neurons in the substantia nigra pars compacta, which results in motor alterations. |
2022-11-25 |
2023-08-14 |
human |
| Yao-Lin Li, Zhong-Xuan Wang, Chang-Zhou Ying, Bao-Rong Zhang, Jia-Li P. Decoding the Role of Familial Parkinson's Disease-Related Genes in DNA Damage and Repair. Aging and disease. vol 13. issue 5. 2022-10-03. PMID:36186134. |
parkinson's disease (pd) is a neurodegenerative disease characterized by the degeneration of midbrain substantia nigra pars compacta dopaminergic neurons and the formation of lewy bodies. |
2022-10-03 |
2023-08-14 |
Not clear |
| Christian Ardianto, Robert Shen, Jimmy F A Barus, Poppy Kristina Sasmita, Yuda Turana, Lilis Lilis, Veronika Maria Sidhart. Secretome as neuropathology-targeted intervention of Parkinson's disease. Regenerative therapy. vol 21. 2022-09-12. PMID:36092507. |
parkinson's disease (pd) is the second most common progressive neurodegenerative disease, characterized by apoptosis of dopaminergic neurons in substansia nigra pars compacta (snpc) caused by ⍺-synuclein aggregation. |
2022-09-12 |
2023-08-14 |
Not clear |
| Nicola Montemurro, Nelida Aliaga, Pablo Graff, Amanda Escribano, Jafeth Lizan. New Targets and New Technologies in the Treatment of Parkinson's Disease: A Narrative Review. International journal of environmental research and public health. vol 19. issue 14. 2022-07-27. PMID:35886651. |
parkinson's disease (pd) is a progressive neurodegenerative disease, whose main neuropathological finding is pars compacta degeneration due to the accumulation of lewy bodies and lewy neurites, and subsequent dopamine depletion. |
2022-07-27 |
2023-08-14 |
Not clear |
| Theodora Mourtzi, Ilias Kazani. Endogenous Neural regeneration research. vol 17. issue 12. 2022-06-06. PMID:35662194. |
endogenous parkinson's disease is the second most common neurodegenerative disease and has currently no effective treatment, one that would be able to stop or reverse the loss of dopaminergic neurons in the substantia nigra pars compacta. |
2022-06-06 |
2023-08-14 |
Not clear |
| Hung-Te Hsu, Ya-Lan Yang, Wan-Hsuan Chang, Wei-Yu Fang, Shu-Hung Huang, Shah-Hwa Chou, Yi-Ching L. Hyperbaric Oxygen Therapy Improves Parkinson's Disease by Promoting Mitochondrial Biogenesis via the SIRT-1/PGC-1α Pathway. Biomolecules. vol 12. issue 5. 2022-05-28. PMID:35625589. |
pd is a neurodegenerative disease characterized by the progressive loss of dopaminergic neurons in the substantia nigra pars compacta (snpc). |
2022-05-28 |
2023-08-13 |
mouse |
| Deepika Np, Md Habibur Rahman, Sandhya Chipurupalli, Shilpa Tn, Basavan Duraiswam. Emerging Role of Marine Natural Products for the Treatment of Parkinson's Disease. CNS & neurological disorders drug targets. 2022-05-13. PMID:35546747. |
parkinson's disease (pd), known as parkinsonism, is a neurodegenerative disease that mainly affects the elderly and is characterized by an extensive and progressive loss of dopaminergic neurons in the substantia nigra pars compacta (snpc). |
2022-05-13 |
2023-08-13 |
Not clear |
| Jianjun Xu, Etsuko Minobe, Masaki Kameyam. Ca Frontiers in cellular neuroscience. vol 16. 2022-05-02. PMID:35496903. |
ca parkinson's disease (pd), a common neurodegenerative disease characterized by motor dysfunction, results from the death of dopaminergic neurons in the substantia nigra pars compacta (snc). |
2022-05-02 |
2023-08-13 |
Not clear |
| Katarzyna Kaczyńska, Magdalena Ewa Orłowska, Kryspin Andrzejewsk. Respiratory Abnormalities in Parkinson's Disease: What Do We Know from Studies in Humans and Animal Models? International journal of molecular sciences. vol 23. issue 7. 2022-04-12. PMID:35408858. |
parkinson's disease (pd) is the second most common progressive neurodegenerative disease characterized by movement disorders due to the progressive loss of dopaminergic neurons in the ventrolateral region of the substantia nigra pars compacta (snpc). |
2022-04-12 |
2023-08-13 |
human |
| Tao Dang, Wen-Jing Cao, Rong Zhao, Ming Lu, Gang Hu, Chen Qia. ATP13A2 protects dopaminergic neurons in Parkinson's disease: from biology to pathology. Journal of biomedical research. 2022-04-07. PMID:35387901. |
as we all know, pd is a neurodegenerative disease characterized by the loss of da neurons in the substantia nigra pars compacta. |
2022-04-07 |
2023-08-13 |
Not clear |
| Lan-Hsin Nancy Lee, Chen-Syuan Huang, Hsiang-Hao Chuang, Hsing-Jung Lai, Cheng-Kai Yang, Ya-Chin Yang, Chung-Chin Ku. An electrophysiological perspective on Parkinson's disease: symptomatic pathogenesis and therapeutic approaches. Journal of biomedical science. vol 28. issue 1. 2021-12-10. PMID:34886870. |
parkinson's disease (pd), or paralysis agitans, is a common neurodegenerative disease characterized by dopaminergic deprivation in the basal ganglia because of neuronal loss in the substantia nigra pars compacta. |
2021-12-10 |
2023-08-13 |
Not clear |
| Chao Gu, Yajing Chen, Yan Chen, Chun-Feng Liu, Zengyan Zhu, Mei Wan. Role of G Protein-Coupled Receptors in Microglial Activation: Implication in Parkinson's Disease. Frontiers in aging neuroscience. vol 13. 2021-12-07. PMID:34867296. |
parkinson's disease (pd) is one of the prevalent neurodegenerative diseases associated with preferential loss of dopaminergic (da) neurons in the substantia nigra compacta (snc) and accumulation of α-synuclein in da neurons. |
2021-12-07 |
2023-08-13 |
Not clear |